| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1421.4B | ¥1452.6B | -2.2% |
| Operating Income | ¥72.0B | ¥206.6B | -65.1% |
| Ordinary Income | ¥66.3B | ¥211.0B | -68.6% |
| Net Income | ¥47.8B | ¥164.7B | -71.0% |
| ROE | 3.7% | 12.0% | - |
FY2026 Q3 results for Socionext reflected significant profitability pressure amid demand adjustments and inventory buildup. Revenue declined 2.2% YoY to 142.1B yen, while Operating Income fell 65.1% to 7.2B yen, Ordinary Income decreased 68.6% to 6.6B yen, and Net Income dropped 71.0% to 4.8B yen. Operating margin contracted 910 basis points to 5.1% from 14.2% YoY, driven by gross margin compression of approximately 840 basis points to 46.3%. The sharp profit decline stemmed from unfavorable product mix, customer inventory adjustments, and price revision lags, compounded by foreign exchange losses of 0.8B yen in non-operating expenses. Despite maintaining a strong balance sheet with equity of 128.9B yen and current ratio of 364.7%, cash generation weakened substantially with operating cash flow of 2.8B yen versus 23.5B yen prior year, resulting in negative free cash flow of 15.7B yen. The company continued shareholder returns with 8.9B yen in dividends and 5.0B yen in share buybacks, exceeding internal cash generation. Full-year guidance calls for revenue of 190.0B yen, operating income of 10.0B yen, and net income of 6.7B yen, requiring Q4 margin recovery and inventory normalization to achieve targets.
[Profitability] ROE of 3.7% represents a significant decline from prior levels, decomposed into net profit margin 3.4%, asset turnover 0.87x, and financial leverage 1.27x. The primary driver of ROE deterioration was net profit margin compression, with operating margin contracting to 5.1% from 14.2% YoY. Gross margin declined approximately 840 basis points to 46.3%, reflecting unfavorable product mix, customer inventory adjustments, and price revision timing gaps. EBITDA of 19.5B yen generated an EBITDA margin of 13.7%, demonstrating maintenance of core operational capability despite profitability pressure. Operating leverage turned negative as selling, general and administrative expenses of 58.6B yen remained relatively fixed against declining gross profit, limiting absorption efficiency. [Cash Quality] Cash and deposits of 38.8B yen provide 2.76x coverage of current liabilities excluding payables and accruals, maintaining adequate liquidity buffers. Operating cash flow to net income ratio of 0.58x indicates earnings quality concerns, primarily driven by working capital consumption from inventory buildup totaling 15.7B yen. [Investment Efficiency] Total asset turnover of 0.87x reflects efficiency headwinds from elevated inventory levels, with work-in-progress increasing 114.7% and finished goods rising 54.9% YoY. Receivables turnover and collection patterns remain stable. [Financial Health] Equity ratio of 78.9% versus total assets of 163.3B yen demonstrates exceptionally strong capitalization. Current ratio of 364.7% and quick ratio at comparable levels indicate robust short-term liquidity. Debt-to-equity ratio of 0.27x represents minimal financial leverage with total liabilities of 34.4B yen, of which current liabilities comprise 32.3B yen. Interest-bearing debt remains minimal with long-term lease obligations of 1.2B yen. Net cash position remains positive despite period cash consumption.
Operating cash flow of 2.8B yen represents 0.58x net income, signaling substantial earnings quality concerns driven by working capital deterioration. The primary cash consumption factor was inventory increase of 15.7B yen, comprising work-in-progress expansion of 12.2B yen and finished goods buildup of 3.5B yen, reflecting production lead times and slower shipment cadence. Accounts payable increased 3.8B yen or 32.0%, partially offsetting inventory-related cash outflows through extended supplier credit utilization. Investing cash flow of negative 18.5B yen comprised property, plant and equipment purchases of 10.8B yen and intangible asset acquisitions of 7.8B yen, continuing capacity and development investments. The CapEx-to-depreciation ratio of 0.88x indicates maintenance-level capital spending with modest growth investment. Asset disposals generated 1.8B yen in proceeds, contributing to period cash management. Financing cash flow of negative 14.1B yen reflected dividends of 8.9B yen and share repurchases of 5.0B yen, totaling 13.9B yen in shareholder distributions. Free cash flow of negative 15.7B yen indicates total shareholder returns exceeded internal cash generation capacity by approximately 28.9B yen. Consequently, cash and deposits declined 34.0B yen or 46.7% to 38.8B yen, representing substantial drawdown of liquidity buffers. Working capital efficiency deteriorated with inventory buildup constraining near-term cash conversion, necessitating inventory normalization and shipment acceleration to restore positive free cash flow generation.
Ordinary income of 6.6B yen compared to operating income of 7.2B yen reflects net non-operating expense contribution of approximately 0.6B yen. Non-operating expenses were primarily driven by foreign exchange losses of 0.8B yen, partially offset by interest and dividend income. The non-operating impact represents 0.4% of revenue, within normal ranges for operational currency exposures and financial activities. At the extraordinary level, gain on sale of fixed assets of 1.8B yen provided material support to net income, though this represents non-recurring event income. The operating cash flow to net income ratio of 0.58x raises earnings quality concerns, as cash generation significantly lagged reported profits. This divergence stems primarily from working capital consumption of 15.7B yen in inventory buildup, indicating that reported earnings included substantial non-cash components tied to production rather than completed sales. Accruals assessment shows operating profit increasingly disconnected from cash realization due to inventory accumulation in work-in-progress and finished goods, suggesting shipment timing mismatches or demand softness. The sustainability of current profitability depends critically on successful conversion of elevated inventory to sales in subsequent periods. Tax cash payments declined in line with reduced pretax income. Overall earnings quality warrants monitoring given the significant operating cash flow shortfall relative to reported profits and dependency on inventory normalization for cash conversion.
Demand environment risk from prolonged customer inventory adjustments and end-market weakness could extend gross margin pressure and inventory buildup beyond Q4, delaying profitability recovery and potentially requiring inventory write-downs. Current work-in-progress increase of 12.2B yen and finished goods buildup of 3.5B yen represent 11.0% of total assets, creating obsolescence risk if demand patterns shift or technology cycles accelerate. Liquidity pressure risk from sustained negative free cash flow combined with high payout commitments, as current shareholder returns of 13.9B yen representing 289% of net income and 498% of operating cash flow are unsustainable without cash flow recovery. Cash reserves declined 46.7% to 38.8B yen, and continuation of current burn rate would materially erode financial flexibility within 2-3 quarters absent operational improvement. Operational leverage risk as relatively fixed cost structure of 58.6B yen in SG&A expenses amplifies margin volatility, with full-year guidance requiring Q4 operating margin improvement to approximately 6% from current 5.1% to achieve 10.0B yen operating income target, necessitating approximately 47.9B yen revenue and 2.8B yen operating profit in Q4 alone.
[Industry Position] (Reference - Proprietary Analysis) Profitability: Operating margin of 5.1% falls below the manufacturing industry median of 7.3% (IQR: 4.6%-12.0%) for 2025-Q3, positioning the company in the lower quartile amid period-specific margin compression. Net profit margin of 3.4% similarly underperforms the industry median of 5.4% (IQR: 3.5%-8.9%), reflecting gross margin deterioration from product mix and inventory adjustments. ROE of 3.7% trails the industry median of 4.9% (IQR: 2.8%-8.2%), driven primarily by profitability weakness rather than asset efficiency or leverage positioning. ROA of 2.9% approximates the industry median of 3.3% (IQR: 1.8%-5.1%), indicating competitive asset utilization despite margin headwinds. Financial Health: Equity ratio of 78.9% substantially exceeds the manufacturing industry median of 63.9% (IQR: 51.5%-72.3%), demonstrating top-quartile balance sheet strength. Current ratio of 3.65x outperforms the industry median of 2.67x (IQR: 2.00x-3.56x), confirming superior liquidity positioning. Net debt position remains negative, comparing favorably to industry median Net Debt/EBITDA of negative 1.11x, as the company maintains net cash status. Efficiency: Revenue decline of 2.2% YoY underperforms the industry median growth of positive 2.8% (IQR: -0.9%-7.9%), placing the company below median on top-line momentum. The company's historical operating margin trajectory shows significant deterioration to 5.1% in 2026-Q3 from double-digit levels in prior periods, reflecting cyclical pressures in the semiconductor value chain. Overall, the company demonstrates superior financial stability relative to manufacturing peers but faces near-term profitability and growth challenges requiring operational recovery. (Industry: Manufacturing sector, N=65 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Margin recovery trajectory represents the critical near-term focal point, as achieving full-year guidance requires Q4 operating margin expansion to approximately 6% from current 5.1%, dependent on successful inventory normalization, favorable product mix shift, and demand stabilization. The company's gross margin compression of 840 basis points to 46.3% and operating margin contraction of 910 basis points to 5.1% demonstrate significant cyclical sensitivity, with recovery timing tied to customer inventory depletion and semiconductor demand cycle inflection. Historical profitability levels indicate substantial operating leverage potential upon demand recovery. Capital allocation sustainability requires reassessment, as total shareholder returns of 13.9B yen representing 289% of net income and 498% of operating cash flow substantially exceed internal generation capacity. While exceptional balance sheet strength with 78.9% equity ratio and 38.8B yen cash provides near-term buffer, continuation of current payout levels absent cash flow recovery would materially erode financial flexibility. Payout policy alignment with normalized earnings and cash generation represents a key consideration for sustainable capital allocation. Inventory management execution will determine cash conversion quality, with 15.7B yen inventory increase representing the primary driver of negative 15.7B yen free cash flow. Work-in-progress expansion of 12.2B yen and finished goods buildup of 3.5B yen require successful conversion to sales in Q4 and beyond to restore positive cash generation. The company's ability to accelerate shipments, optimize production scheduling, and align inventory levels with demand will directly impact cash flow recovery and operational efficiency restoration in coming quarters.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.